|
Characteristics
|
FH patients (n = 285)
|
|---|
|
Baseline Data
|
|
Male, n (%)
|
173 (60.7%)
|
|
Age, year
|
49 ± 12
|
|
BMI, kg/(m2)
|
25.32 ± 3.74
|
|
SBP, mm/Hg
|
125 ± 17.0
|
|
DBP, mm/Hg
|
78 ± 11.5
|
|
Glucose, mmol/L
|
5.54 ± 1.47
|
|
Xanthoma, n(%)
|
28 (9.8%)
|
|
CAD, n (%)
|
233 (81.8%)
|
|
Family history of CAD, n (%)
|
124 (43.5%)
|
|
Region distribution
|
|
northeast China
|
65 (22.8%)
|
|
north China
|
160 (56.1%)
|
|
northwest China
|
12 (4.2%)
|
|
eastern China
|
38 (13.3%)
|
|
southern China
|
8 (2.8%)
|
|
southwest China
|
2 (0.7%)
|
|
Lipids
|
|
TC, mmol/L
|
7.03 ± 2.53
|
|
HDL-C, mmol/L
|
1.09 ± 0.32
|
|
LDL-C, mmol/L
|
5.22 ± 2.12
|
|
Untreated LDL-C, mmol/L
|
7.86 ± 2.25
|
|
TG, mmol/L
|
1.67 (1.20–2.14)
|
|
ApoA, g/L
|
1.31 ± 0.33
|
|
ApoB, g/L
|
1.47 ± 0.49
|
|
Statin, n (%)
|
231 (81.1%)
|
|
Ezetimibe, n (%)
|
17 (6.0%)
|
- Data are expressed as mean ± SD, median (25th–75th percentile) or n (%)
- FH familial hypercholesterolemia, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, CAD coronary artery disease, TC total cholesterol, HDL-C HDL cholesterol, LDL-C LDL cholesterol, TG triglyceride, apo A apolipoprotein A, apo B apolipoprotein B
